Glaucoma drug helps restore vision loss linked to obesity

June 26, 2014 by Jim Dryden
Glaucoma drug helps restore vision loss linked to obesity
Working with colleagues at 38 centers nationwide, Washington University neuro-ophthalmologist Gregory P. Van Stavern, MD, has found that combining a glaucoma drug with a weight-loss program can improve vision in patients with the disorder known as idiopathic intracranial hypertension. Credit: Robert Boston

(Medical Xpress)—A new study shows that the eyesight of patients with an unusual vision disorder linked to obesity improves twice as much if they take a glaucoma drug and lose a modest amount of weight than if they only lose weight.

The condition, called idiopathic intracranial hypertension, affects an estimated 100,000 people in the United States. Most are obese women ages 20 to 50.

The researchers recently reported their results in The Journal of the American Medical Association.

The condition's most common symptoms are headaches and vision problems, including blind spots, poor peripheral vision, double vision and temporary episodes of blindness. Five to 10 percent of women with the disorder experience disabling vision loss. Only about 5 percent of cases involve men.

"The condition results in elevated pressure in the fluid surrounding the brain and the spinal cord," said co-author Gregory P. Van Stavern, MD, a neuro-ophthalmologist at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis. "We don't completely understand the disorder but know it affects the optic nerve because when fluid pressure is elevated, the optic nerve is swollen when we examine the eye."

Previous research has found that losing 5 to 10 percent of body weight can improve symptoms in many patients. The glaucoma drug used in the study, acetazolamide, is a diuretic given to glaucoma patients to reduce pressure in the eye. Many eye specialists also have prescribed the drug—given as a pill rather than eye drops—to reduce fluid production in and around the brain.

The disorder also is called pseudotumor cerebri because its symptoms resemble those of a brain tumor, and it is becoming more common as the obesity epidemic grows. In developing countries where obesity is uncommon, very few cases of idiopathic intracranial hypertension exist, Van Stavern said.

The study was conducted at 38 clinical sites in the United States and included 161 women and four men with the disorder and mild vision loss.

At the time subjects enrolled in the study, their average body mass index (BMI) was about 40. A BMI of 30 or greater is considered obese.

Participants were placed on an exercise plan and diet designed to lower salt intake and cut 500 to 1,000 calories each day. The goal was to get subjects to lose at least 6 percent of their body weight. In addition to dietary advice, all study subjects were provided with a weight-loss coach and low-cost exercise equipment.

About half of the participants also randomly were chosen to receive acetazolamide. When the study began, subjects received 1 gram of the drug per day. The dose then was increased by a quarter of a gram each week until study patients reached their maximum tolerated dose or were taking up to 4 grams of the drug daily. The other participants received an inactive placebo with escalating "dosages" during the study.

"Acetazolamide makes certain foods and carbonated beverages taste really bad," said Van Stavern, an associate professor of ophthalmology and visual sciences and of neurology. "Some experts thought that acetazolamide might be causing people to lose weight just because they avoided foods that didn't taste good."

But the researchers found an additional benefit in participants taking the drug. After six months, patients in both study groups had improved vision. But for those who lost weight and took the drug, eyesight improved almost twice as much as in those who lost weight but got the placebo.

At the end of the study, those who took the glaucoma drug also had less swelling in the than those who lost weight and received the placebo. The drug-weight loss combination also was linked to greater improvements in daily function and quality of life.

"So although both groups did well, the patients who took the drug and did the weight-loss regimen fared much, much better," Van Stavern explained. "Their vision improvement was independent of the fact that the drug makes some foods taste lousy."

Van Stavern said he expects more information will be culled from the data over the next few years. Several hormones and a number of genes have been linked to idiopathic intracranial hypertension, and those factors are being analyzed. But for now, the researchers said many patients stand to benefit.

"This study provides a much-needed evidence base for using acetazolamide as an adjunct to weight loss," said Michael Wall, MD, the national director of the study and a professor of neurology and ophthalmology at the University of Iowa in Iowa City. "This has been around since the 1950s, and prior studies have found varying degrees of efficacy. One strength of our study is that we slowly introduced patients to the highest tolerated dose in an attempt to maximize efficacy while limiting side effects."

Explore further: Glaucoma drug helps women with blinding disorder linked to obesity

More information: Wall M, et al for the NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, "Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial." The Journal of the American Medical Association, vol. 311 (16), pp. 1641-1651. April 23/30, 2014. DOI: 10.1001/jama.2014.3312

Related Stories

Glaucoma drug helps women with blinding disorder linked to obesity

April 22, 2014
An inexpensive glaucoma drug, when added to a weight loss plan, can improve vision for women with a disorder called idiopathic intracranial hypertension (IIH), according to a study funded by the National Institutes of Health.

Medication helps improve vision for patients with neurological disorder

April 22, 2014
In patients with idiopathic intracranial hypertension and mild vision loss, the use of the drug acetazolamide, along with a low-sodium weight-reduction diet, resulted in modest improvement in vision, compared with diet alone, ...

Researcher tests drug's impact on neurological disease affecting women

June 7, 2011
A rare but increasingly more common disease striking overweight, younger women is the focus of a clinical trial at Michigan State University, where an osteopathic physician is testing the effectiveness of a certain drug against ...

Diabetes drug appears to work for weight management, reversing prediabetes

June 23, 2014
Nondiabetic obese and overweight people lose more weight, are more likely to reverse prediabetes and are slower to develop type 2 diabetes when they take the diabetes drug liraglutide in addition to dieting and exercising, ...

Diabetes drug may spur weight loss in obese nondiabetics

May 30, 2014
(HealthDay)—A higher dose of the diabetes drug liraglutide (Victoza) may help obese people without the disease lose weight, a new study suggests.

Diabetes drug, Liraglutide, improves risk factors for heart disease

June 23, 2014
Treatment with the diabetes drug liraglutide, in combination with diet and exercise, led to a significant reduction in weight and improved a number of cardiovascular risk factors, including high blood pressure and high cholesterol, ...

Recommended for you

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

Nearly 60% of pinkeye patients receive antibiotic eye drops, but they're seldom necessary

June 28, 2017
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.

Magnetic implants used to treat 'dancing eyes'

June 26, 2017
A research team has successfully used magnets implanted behind a person's eyes to treat nystagmus, a condition characterised by involuntary eye movements.

Drug shows promise against vision-robbing disease in seniors

June 21, 2017
An experimental drug is showing promise against an untreatable eye disease that blinds older adults—and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision.

Reproducing a retinal disease on a chip

June 15, 2017
Approximately 80% of all sensory input is received via the eyes, so suffering from chronic retinal diseases that lead to blindness causes a significant decrease in the quality of life (QOL). And because retinal diseases are ...

New gene therapy for vision loss proven safe in humans

May 16, 2017
In a small and preliminary clinical trial, Johns Hopkins researchers and their collaborators have shown that an experimental gene therapy that uses viruses to introduce a therapeutic gene into the eye is safe and that it ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

aya
not rated yet Jun 26, 2014
This drug seems to be very beneficial. I was unaware until recently that obesity could have an effect on vision.

The ability to get rid of unnecessary fat in particular is something that could help regarding diabetes and obesity for example. I am saying this based on my understanding of what I have read concerning the link between weight loss and these conditions.

A video I have watched the first time not extremely long ago gave me information that I was not necessarily expecting about weight loss. There is a link to it on this page: specialfatloss.com

However, I don't believe in depriving oneself completely from delicious, tasty and lawful food just to follow a particular diet. If it can be followed over the long term, does it truly help?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.